Yangzhou Huitong Technology Corp.,
301601
Scantech
688583
KAISA JiaYun Technology Inc.
300242
Fuchun Technology
300299
Hangzhou Onechance Tech Corp.
300792
CN Stock MarketDetailed Quotes
600056 China Meheco Group
- 10.70
- -0.08-0.74%
Market Closed Jan 15 15:00 CST
16.01BMarket Cap17.77P/E (TTM)
10.80High10.64Low96.80KlotVolume10.79Open10.78Pre Close103.60MTurnover0.65%Turnover Ratio15.26P/E (Static)1.50BShares13.8852wk High1.37P/B16.00BFloat Cap9.4552wk Low11.86Limit Up1.50BShs Float31.11Historical High9.70Limit Down1.48%Amplitude-1.82Historical Low0.23Dividend TTM10.70Avg Price52.02KlotAsk2.17%Div YieldTTM100Lot Size41.53KlotBid
China Meheco Group News
2025 First Extraordinary General Meeting of Shareholders Meeting Materials
China Pharmaceutical: Announcement on Subsidiary Drugs Passing Conformity Assessment of Generic Drugs
Announcement on the subsidiary\'s drug passing the generic drug consistency evaluation
China Pharmaceutical: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025
China Pharmaceuticals: Announcement on Relinquishing Priority Purchase Rights for Some Shares in Participating Companies
China Pharmaceutical: Announcement of Resolutions of the 22nd Meeting of the 9th Board of Directors
Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025
Announcement on relinquishing the right to preferential purchase of some shares in participating companies
Announcement of Resolutions of the 22nd Meeting of the 9th Board of Directors
Announcement on providing guarantees for holding companies
Announcement on the subsidiary\'s drug passing the generic drug consistency evaluation
Announcement on receipt of the letter of commitment from the controlling shareholder
China Pharmaceutical: Progress Notice on Important Shareholding Companies Planning to Change Actual Controllers
Announcement on the progress of important shareholding companies planning to change the actual controller
Announcement on the progress of the company\'s litigation matters
Announcement on the subsidiary participating in the 10th batch of national collection to be selected
Legal Opinion on the 5th Extraordinary General Meeting of Shareholders of China Pharmaceutical and Health Industry Co., Ltd. in 2024
Announcement of Resolutions of the Fifth Extraordinary General Meeting of Shareholders in 2024
China Pharmaceuticals: Announcement on Subsidiaries Obtaining Drug Registration Approvals
China Pharmaceutical: 2024 Fifth Extraordinary General Meeting of Shareholders Meeting Information
